Keynote Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Sell
1,904
-63
-3% -$63.9K 0.93% 30
2025
Q4
$2.11M Sell
1,967
-60
-3% -$57.4K 1.18% 17
2025
Q3
$1.55M Buy
2,027
+125
+7% +$93K 0.93% 26
2025
Q2
$1.48M Buy
1,902
+15
+0.8% +$11.7K 1% 28
2025
Q1
$1.56M Buy
1,887
+2
+0.1% +$1.66K 1.11% 23
2024
Q4
$1.46M Buy
1,885
+110
+6% +$91.1K 1.12% 22
2024
Q3
$1.57M Sell
1,775
-241
-12% -$217K 1.2% 20
2024
Q2
$1.83M Buy
2,016
+5
+0.2% +$4K 1.53% 14
2024
Q1
$1.56M Buy
+2,011
New +$1.43M 1.31% 17

Other funds holding LLY

Keynote Financial Services's LLY Position: Q1 2026 in Review

Keynote Financial Services reduced its Eli Lilly (LLY) stake by 3.2% in Q1 2026, selling an estimated $63.9K and leaving 1,904 shares worth $1.75M. The position accounts for 0.93% of the portfolio, ranked #30.

Keynote Financial Services first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.11M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Keynote Financial Services held 1,904 shares of Eli Lilly worth $1.75M as of Q1 2026.
  • Keynote Financial Services sold 63 Eli Lilly shares in Q1 2026, an estimated $63.9K.
  • Eli Lilly made up 0.93% of Keynote Financial Services's portfolio in Q1 2026, its #30 holding.
  • Keynote Financial Services first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Keynote Financial Services's Eli Lilly position peaked at $2.11M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Keynote Financial Services's 13F filing for Q1 2026, filed 13 May 2026.